Elite Pharmaceuticals ELTP
OTC ELTP
$0.25 +0.00 (+0.00%)
At close: Oct 15, 2026 · 4:00 PM EDT

Elite Pharmaceuticals (ELTP) Net Preferred Shares Issued and Repurchased (2011 - 2012)

Updated

Analysis

Elite Pharmaceuticals (ELTP) Net Preferred Shares Issued and Repurchased (2011 - 2012) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Pref. Shares Issued (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn -
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn -
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn -
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn -
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn -
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn -
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn -
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -
10 Elite Pharmaceuticals 258.43 Mn 140.10 Mn 13.51 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2012 250,000.00
Jun 30, 2012 187,500.00
Mar 31, 2012 125,000.00
Sep 30, 2011 125,000.00
API Access

Elite Pharmaceuticals Net Preferred Shares Issued and Repurchased API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=net-preferred-shares-issued-and-repurchased&ticker=ELTP&period=max&api_key=YOUR_API_KEY